-
EC calls on Italy to amend its pharmacy ownership rules
1 Dec 08 | 15.47 | EU
The European Commission has asked the Italian government to amend legislation that bans pharmacists from owning more than one pharmacy and restricts the number of pharmacies a group of pharmacists can own to four more >
-
Pharmaceutical companies blocking generics
28 Nov 08 | 15.05 | EU
Many pharmaceutical companies appear to be using delaying or blocking tactics to prevent generic companies from marketing medicines, thus stifling innovation, the European Commission says in a preliminary report from its pharmaceutical sector antitrust inquiry more >
-
Ionsys marketing authorisation suspended
21 Nov 08 | 17.03 | EU
Janssen-Cilag’s Ionsys (fentanyl iontophoretic transdermal system) has had its marketing authorisation suspended across Europe, following its September recall, after the European Medicines Agency (EMEA) concluded that the post-operative pain product’s benefits no longer outweigh its risk more >
-
e-Bug to help children
20 Nov 08 | 16.31 | EU
A new EU initiative, “e-Bug”, to teach children about the sensible use of antibiotics was demonstrated as part of the first Europeanantibiotic awareness day on 18 November 2008
more > -
Pfizer withdraws EU application to switch sildenafil to non-prescription medicine
20 Nov 08 | 15.45 | EU
Pfizer announced today (20 November 2008) that it has withdrawn its application to switch the legal status of sildenafil (Viagra) from prescription only to non-prescription status in the EU more >
-
Promoting prudent use of antibiotics
13 Nov 08 | 17.51 | EU
18 November 2008 is EU Antibiotic Awareness Day. Esmita Charani and Jonathan Cooke, of the Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection, explain the importance of this new campaign more >
-
Study looks at cancer risk among women taking B vitamins for CVD prevention
6 Nov 08 | 15.46 | EU
Treatment with combined folic acid, vitamin B6, and vitamin B12 has no effect on the overall risk of invasive cancer, including breast cancer, among women at high risk for cardiovascular disease, according to a study published
more > -
End of the road for rimonabant
6 Nov 08 | 13.40 | EU
Sanofi-aventis has announced that it is to discontinue the ongoing rimonabant (Acomplia) clinical development programme in all indications more >
-
European Medicines Agency approves POM-to-P orlistat switch
30 Oct 08 | 16.17 | EU
Orlistat 60mg (Alli) has been recommended as a non-prescription product by the European Medicines Agency’s Committee for Medicinal Products for Human Use
more > -
Rimonabant marketing authorisation suspended: update
24 Oct 08 | 14.39 | EU
Rimonabant (Acomplia) has had its marketing authorisation suspended across the EU following a safety review by the European Medicines Agency (EMEA). The review, initiated because of growing concerns about psychiatric side effects, has revealed that the risks of treatment outweigh any clinical benefits more >
Hello guest, welcome to PJ online
gateway to the world of pharmacy and medicines
